We have a strong R&D team which is experienced in the pharmaceutical industry and is specialised in fields such as medicinal chemistry, pharmacy, pharmacology and product development.
Our team is supported by alliances with top research institutes within the PRC.
We have been conducting R&D on pharmaceutical products for liver and digestive system related conditions since 1996.

We are one of only five pharmaceutical companies which are licensed by the State Food & Drug Administration to produce ATT tablets in the PRC. Thus we are in a good position to tap the demand for ATT tablets.

As a traditional Chinese medicine preparation protection product, we have the raw material of Huangcao of Gulin Gansu Granules, which is produced in Gulin County, Sichuan Province.
Gulin Gansu was awarded the "People's Republic of China Origin and Geographical Indication Product", becoming the first traditional Chinese medicine preparation product in China to obtain this protection and recognition.

Our extensive sales and marketing network in most provinces, municipals and autonomous regions in the PRC enhances customer service and ensures timely delivery and wider reach of our products.

Our products are sold to approximately 2,000 hospitals located in many cities within the PRC .

Due to our marketing strategies, our brands "国嘉" and "古蔺肝苏" are well recognised brand names in the PRC and are associated with delivering quality and safe products. Our products and innovations have received numerous awards.

An experienced management team led by our CEO and Executive Director, Wu Xuedan, who has many years of experience in the pharmaceutical industry and is supported by a team of experienced managers.